Form 4: Journey Medical Corp CFO Benesch Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Journey Medical Corp's CFO, Joseph Benesch, sold 1,365 shares to cover tax obligations related to vesting restricted stock units.

Summary

  • On February 21, 2025, Joseph Benesch, CFO of Journey Medical Corp, sold 1,365 shares of common stock at a price of $5.19 per share.
  • The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units on February 20, 2025.
  • Benesch had no discretion over the sale, which was conducted automatically according to the company's policies.
  • Following the transaction, Benesch beneficially owns 45,966 shares, including restricted stock units that vest over time.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock sale for tax purposes. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This sale appears to be routine, covering tax obligations related to equity compensation.

Stakeholder Impact

  • The sale of shares by an insider could have a minor impact on shareholder sentiment, but the reason for the sale (tax obligations) is generally viewed as neutral.

Key Dates

DateDescription
02/20/2025Restricted stock units vested, triggering tax obligations.
02/21/2025Sale of 1,365 shares to cover tax obligations.
02/24/2025Date of signature for the Form 4 filing.

Keywords

Form 4, Journey Medical Corp, DERM, Joseph Benesch, CFO, Stock Sale, Restricted Stock Units, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.